Literature DB >> 7356728

A murine C4 molecule with reduced hemolytic efficiency.

J P Atkinson, K McGinnis, L Brown, J Peterein, D Shreffler.   

Abstract

C4 functional activity and antigenic levels were determined in H-2-congenic mouse strains. In strains with the H-2w7 haplotype, the C4 hemolytic activity per unit of residual Ss antigenic activity, after depletion of the nonfunctional Slp-positive molecules was 25-33% that found with other H-2 haplotypes. This reduced hemolytic efficiency was not the result of either a more labile C4 molecule or of the presence of inhibitors. Moreover, other strains with comparable antigenic concentrations of Ss (C4) and Slp has three- to fourfold higher levels of C4 hemolytic activity. Based on these data and previously reported structural differences between C4 molecules from the H-2w7 haplotype compared with other standard H-2 haplotypes, the reduced hemolytic efficiency of this molecule is probably secondary to alterations in the structure of its alpha-chain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356728      PMCID: PMC2185785          DOI: 10.1084/jem.151.2.492

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Identification of Ss protein as murine C4.

Authors:  P J Lachmann; D Grennan; A Martin; P Demant
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  H-2 linked Ss protein is C4 component of complement.

Authors:  B Curman; L Ostberg; L Sandberg; I Malmheden-Eriksson; G Stålenheim; L Rask; P A Peterson
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

3.  Hereditary angioedema: the clinical syndrome and its management.

Authors:  M M Frank; J A Gelfand; J P Atkinson
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

4.  Hemolytic efficiencies of genetic variants of human C3.

Authors:  H R Colten; C A Alper
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

5.  Enhancement of hemolytic complement activity by treatment of human serum with iodine.

Authors:  M J Polley
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

6.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through identification of its human homologue as the fourth component of complement.

Authors:  T Meo; T Krasteff; D C Shreffler
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

8.  The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement.

Authors:  P Démant; J Capková; E Hinzová; B Vorácová
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

9.  The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.

Authors:  C A Alper; I Goodkofsky; I H Lepow
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system.

Authors:  T H Hansen; H S Shin; D C Shreffler
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  10 in total

Review 1.  H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilation.

Authors:  J P Atkinson; D R Karp; E P Seeskin; C C Killion; P A Rosa; S L Newell; D C Shreffler
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  Genetic and structural characterization of H-2-controlled allelic forms of murine C4.

Authors:  K L Parker; J P Atkinson; M H Roos; D C Shreffler
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

3.  Multiple C4/Slp genes distinguished by expression after transfection.

Authors:  D M Robins; M Malissen; L Hood; A Ferreira; D Walthall; M Mitchell
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

4.  Sequence comparison of alleles of the fourth component of complement (C4) and sex-limited protein (Slp).

Authors:  C Hemenway; M Kalff; J Stavenhagen; D Walthall; D Robins
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

5.  Amino acid sequence homologies and glycosylation differences between the fourth component of murine complement and sex-limited protein.

Authors:  D R Karp; K L Parker; D C Shreffler; C Slaughter; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Characterization of the Mr difference between secreted murine fourth component of complement and the major plasma form: evidence for carboxyl-terminal cleavage of the alpha chain.

Authors:  D R Karp; D C Shreffler; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  H-2-linked murine factor B phenotypes.

Authors:  E S Paolucci; D C Shreffler
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Complete cDNA sequence of the fourth component of murine complement.

Authors:  D S Sepich; D J Noonan; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.

Authors:  T R Dykman; J A Hatch; J P Atkinson
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

Authors:  Erin Mehlhop; Michael S Diamond
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.